You are here

Clinical Trials: Cord Blood

Condition:   Chondral or Osteochondral Lesion of Talus
Interventions:   Biological: CARTISTEM®;   Procedure: Microfracture
Sponsors:   SK bioland co., ltd.;   Medipost Co Ltd.
Enrolling by invitation
Condition:   Severe Acute Respiratory Syndrome (SARS) Pneumonia
Intervention:   Combination Product: Stem Cell Educator-Treated Mononuclear Cells Apheresis
Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Hackensack Meridian Health
Not yet recruiting
Condition:   Hematological Malignancies
Intervention:   Biological: omidubicel
Sponsor:   Gamida Cell ltd
Not yet recruiting
Condition:   Osteoarthritis, Knee
Intervention:   Procedure: umbilical cord blood stem cell implantation for osteoarthritis treatment
Sponsor:   Uijeongbu St. Mary Hospital
Not yet recruiting
Condition:   Spinal Cord Injuries
Intervention:   Other: Stem cell transplantation
Sponsor:   The First Affiliated Hospital of Dalian Medical University
Condition:   Haematologic Disease
Intervention:   Combination Product: CTL 19
Sponsors:   Nantes University Hospital;   INSERM U01232 CRCINA
Not yet recruiting
Conditions:   Safety Issues;   Efficiency
Intervention:   Biological: microtransplantation
Sponsor:   The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
Not yet recruiting
Conditions:   High Risk Hematological Malignancy;   Cord Blood Transplant
Intervention:   Biological: ECT-001-CB (UM171-Expanded Cord Blood Transplant)
Sponsors:   ExCellThera inc.;   Fred Hutchinson Cancer Research Center
Condition:   Cerebral Palsy
Interventions:   Biological: Low HLA group CBU infusion;   Biological: High HLA group CBU infusion;   Other: Standard therapy
Sponsors:   State-Financed Health Facility "Samara Regional Medical Center Dinasty";   INBIO, LLC
Conditions:   Acute Erythroid Leukemia;   Acute Lymphoblastic Leukemia;   Acute Megakaryoblastic Leukemia;   Acute Myeloid Leukemia;   Blasts Under 10 Percent of Bone Marrow Nucleated Cells;   Blasts Under 5 Percent of Bone Marrow Nucleated Cells;   Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Hematopoietic and Lymphoid Cell Neoplasm;   Human Immunodeficiency Virus Positive;   Myelodysplastic Syndrome;   Myelodysplastic Syndrome With Excess Blasts;   Non-Hodgkin Lymphoma;   Refractory Anemia
Interventions:   Drug: Fludarabine;   Drug: Fludarabine Phosphate;   Drug: Cyclophosphamide;   Drug: Thiotepa;   Radiation: Total-Body Irradiation;   Procedure: Umbilical Cord Blood Transplantation;   Other: Cellular Therapy
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI);   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting